home All News open_in_new Full Article

Novo Nordisk cuts sales and profits guidance amid obesity drug competition

The boss of the Wegovy firm linked its reduced guidance to the market for weight-loss treatments being ‘more competitive than ever’.


today 3 d. ago attach_file Economics

attach_file Economics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Events
attach_file Events
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics


ID: 3451506343
Add Watch Country

arrow_drop_down